Vilmundur Gudnason Selected Research

6-sulfatoxymelatonin

1/2021	Exploratory assessment of pineal gland volume, composition, and urinary 6-sulfatoxymelatonin levels on prostate cancer risk.
10/2016	Pineal Gland Volume Assessed by MRI and Its Correlation with 6-Sulfatoxymelatonin Levels among Older Men.
2/2015	Urinary melatonin levels, sleep disruption, and risk of prostate cancer in elderly men.
1/2015	Circadian clock genes and risk of fatal prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vilmundur Gudnason Research Topics

Disease

30	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 10/2005
26	Coronary Disease (Coronary Heart Disease) 01/2022 - 04/2004
24	Type 2 Diabetes Mellitus (MODY) 01/2022 - 03/2005
18	Inflammation (Inflammations) 01/2019 - 06/2003
15	Atherosclerosis 01/2022 - 10/2003
14	Myocardial Infarction 07/2021 - 04/2002
12	Hypertension (High Blood Pressure) 01/2022 - 09/2005
12	Obesity 01/2022 - 11/2010
10	Atrial Fibrillation 01/2022 - 02/2010
10	Heart Failure 12/2021 - 03/2005
9	Alzheimer Disease (Alzheimer's Disease) 06/2022 - 04/2012
9	Stroke (Strokes) 01/2020 - 10/2003
8	Macular Degeneration (Age-Related Maculopathy) 01/2019 - 05/2011
7	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 08/2010
7	Insulin Resistance 07/2019 - 06/2011
7	Chronic Renal Insufficiency 01/2018 - 09/2005
6	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 08/2013
6	Diabetes Mellitus 01/2019 - 03/2008
6	Osteoarthritis 01/2019 - 01/2011
5	Neoplasms (Cancer) 01/2021 - 02/2016
5	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2013
4	Hip Fractures (Intertrochanteric Fractures) 01/2022 - 01/2014
4	Dementia (Dementias) 01/2022 - 04/2012
4	Fibrosis (Cirrhosis) 01/2021 - 03/2011
4	Gout 10/2019 - 12/2010
4	Geographic Atrophy 01/2019 - 05/2011
4	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019 - 12/2010
3	COVID-19 04/2021 - 06/2020
3	Glucose Intolerance 01/2021 - 03/2005
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 01/2018
3	Genetic Risk Score 06/2017 - 11/2014
3	Brain Infarction 09/2015 - 05/2009
3	Vascular Diseases (Vascular Disease) 09/2011 - 12/2009
2	Cognitive Dysfunction 06/2022 - 04/2012
2	Migraine Disorders (Migraine) 01/2022 - 08/2011
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 01/2021
2	Heart Diseases (Heart Disease) 12/2021 - 10/2005
2	Non-alcoholic Fatty Liver Disease 01/2021 - 03/2011
2	Cysts 01/2021 - 10/2016
2	Bronchiectasis 01/2021 - 08/2020
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 10/2020 - 02/2003
2	Aortic Valve Stenosis (Aortic Stenosis) 01/2020 - 11/2014
2	Kidney Diseases (Kidney Disease) 11/2019 - 06/2009
2	Breast Neoplasms (Breast Cancer) 10/2019 - 11/2015
2	Ischemic Stroke 01/2019 - 10/2003
2	Atherosclerotic Plaque (Atheroma) 01/2019 - 01/2017
2	Thinness 04/2018 - 01/2016
2	Arthritis (Polyarthritis) 01/2018 - 02/2013

Drug/Important Bio-Agent (IBA)

24	LipidsIBA 01/2022 - 04/2002
20	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2004
18	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2004
16	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 08/2002
16	CholesterolIBA 01/2021 - 04/2002
13	Triglycerides (Triacylglycerol)IBA 01/2021 - 04/2002
13	C-Reactive ProteinIBA 11/2018 - 04/2004
11	Biological ProductsIBA 01/2022 - 10/2010
10	CreatinineIBA 07/2021 - 09/2005
9	Insulin (Novolin)FDA Link 01/2022 - 06/2007
9	LDL CholesterolIBA 12/2021 - 08/2010
8	CalciumIBA 01/2022 - 12/2010
8	Pharmaceutical PreparationsIBA 12/2021 - 06/2009
7	pro-brain natriuretic peptide (1-76)IBA 07/2021 - 12/2009
7	Apolipoproteins E (ApoE)IBA 01/2021 - 01/2013
7	oxidized low density lipoproteinIBA 10/2020 - 02/2014
7	HDL CholesterolIBA 07/2019 - 08/2010
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 05/2006
6	Uric Acid (Urate)IBA 10/2019 - 03/2005
6	Retinaldehyde (Retinal)IBA 01/2019 - 06/2008
6	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2016 - 12/2009
5	hydroxide ionIBA 12/2021 - 01/2014
5	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 05/2015
4	ApolipoproteinsIBA 06/2022 - 06/2012
4	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022 - 02/2015
4	6-sulfatoxymelatoninIBA 01/2021 - 01/2015
4	Blood Glucose (Blood Sugar)IBA 01/2020 - 10/2005
4	AlbuminsIBA 11/2019 - 03/2016
4	25-hydroxyvitamin DIBA 04/2019 - 01/2014
4	Vitamin D FDA LinkGeneric 01/2018 - 01/2015
4	Cystatin CIBA 01/2018 - 08/2015
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2021 - 10/2015
3	AntibodiesIBA 01/2019 - 12/2005
3	von Willebrand FactorIBA 01/2019 - 04/2004
3	Antihypertensive Agents (Antihypertensives)IBA 01/2018 - 03/2013
3	HDL LipoproteinsIBA 11/2013 - 06/2011
3	Lipoprotein(a)IBA 06/2012 - 03/2008
3	Transcription Factors (Transcription Factor)IBA 12/2010 - 03/2006
2	ElementsIBA 01/2022 - 03/2014
2	MelatoninIBA 01/2021 - 02/2015
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021 - 11/2013
2	Hormones (Hormone)IBA 01/2021 - 01/2012
2	Blood Proteins (Serum Proteins)IBA 01/2020 - 01/2018
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 03/2010
2	Amyloid (Amyloid Fibrils)IBA 01/2019 - 12/2012
2	Carrier Proteins (Binding Protein)IBA 01/2019 - 01/2019
2	Hypoglycemic Agents (Hypoglycemics)IBA 04/2018 - 01/2016
2	Thiosulfate Sulfurtransferase (Rhodanese)IBA 04/2018 - 01/2016

Therapy/Procedure

6	Therapeutics 01/2018 - 02/2014
3	Replacement Arthroplasty 01/2016 - 06/2011
3	Hip Replacement Arthroplasty (Total Hip Replacement) 03/2013 - 08/2005
2	Traction 01/2021 - 08/2020